Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „presented“
Suchtreffer
Begriffe & Kennungen
Aranesp · 4.8 · Data are presented separately for CRF and cancer patients reflecting the different adverse reaction profile in
Eintrag öffnenAranesp · 4.8 · Data presented from controlled studies included 1,357 patients, 766 who received Aranesp and 591 patients who
Eintrag öffnenArava · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenArava · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenArava · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenArexvy · 4.8 · The safety profile presented in Table 1 is based on data from phase 3 clinical studies (RSV OA=ADJ-006, -018 a
Eintrag öffnenAvonex · 4.8 · 19 Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenAvonex · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenBaiama · 4.8 · Within each frequency grouping, adverse drug reactions are presented in order of decreasing seriousness.
Eintrag öffnenBaiama · 4.8 · Within each frequency grouping, adverse drug reactions are presented in order of decreasing seriousness.
Eintrag öffnenBalversa · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenBavencio · 4.8 · These reactions are presented by system organ class and frequency. Frequencies are defined as: very common (≥
Eintrag öffnenBeneFIX · 4.8 · Tabulated list of adverse reactions The table presented below is according to the MedDRA system organ classifi
Eintrag öffnenBeneFIX · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenBenlysta · 4.8 · 55 The data presented in the table below reflect exposure in 674 patients from the three pre-registration clin
Eintrag öffnenBenlysta · 4.8 · Data presented below are pooled from the three pre-registration intravenous clinical studies (10 mg/kg body we
Eintrag öffnenBenlysta · 4.8 · Data presented below are pooled from the three pre-registration intravenous clinical studies (10 mg/kg body we
Eintrag öffnenBenlysta · 4.8 · Data presented below are pooled from the three pre-registration intravenous clinical studies (10 mg/kg body we
Eintrag öffnenBenlysta · 4.8 · The data presented in the table below reflect exposure in 674 patients with SLE from the three pre- registrati
Eintrag öffnenBenlysta · 4.8 · The data presented in the table below reflect exposure in 674 patients with SLE from the three pre- registrati
Eintrag öffnen